SCHEDULE: Manchester Group Boosts SANUWAVE Health Stake to 11.1%

Manchester Management and affiliated entities have increased their beneficial ownership in SANUWAVE Health, Inc. to 11.1% of common stock, reiterating an investment-focused approach.

Summary

• Reporting Persons, including Manchester Management PR, LLC, Manchester Explorer, L.P., Manchester Management Company, LLC, James E. Besser, and Morgan C. Frank, have filed Amendment No. 11 to their Schedule 13D.
• The group's aggregate beneficial ownership in SANUWAVE Health, Inc. common stock is 947,979 shares, representing 11.1% of the outstanding shares.
• Manchester Explorer, L.P. directly owns 863,980 shares, constituting 10.1% of the class.
• James E. Besser beneficially owns 947,979 shares (11.1%), and Morgan C. Frank beneficially owns 916,633 shares (10.7%).
• The outstanding shares figure of 8,576,164 is based on the Issuer's 10-Q filed on November 6, 2025.
• The shares were acquired for investment purposes using personal funds and working capital.
• There are no current plans for extraordinary corporate transactions, changes to the Board or management, capitalization or dividend policy, operating policies, corporate structure, charter or bylaws, delisting, or termination of registration.
• The Reporting Persons reserve the right to pursue such changes, dispose of shares, engage with management and the Board to maximize shareholder value, and act in concert with other shareholders.

Sentiment

Score: 6

Explanation: The filing indicates an increased stake by an investment group with stated intentions to maximize shareholder value, which can be seen as a positive for existing shareholders. However, the 'reserve the right' clauses also introduce potential for future activist actions or share disposals, creating some uncertainty.

Positives

• Increased stake by a significant investment group, potentially signaling confidence in the company's long-term value.
• The Reporting Persons explicitly state their intention to engage with management and the Board to maximize shareholder value.

Risks

• The Reporting Persons reserve the right to dispose of their shares, which could put downward pressure on the stock price if executed in large volumes.
• The Reporting Persons may seek to influence corporate strategy or governance, which could lead to disagreements with current management or the Board.

Future Outlook

The Reporting Persons maintain their investment purpose and reserve the right to engage with SANUWAVE Health's management and Board of Directors to explore alternatives for maximizing shareholder value. They also reserve the right to act in concert with other shareholders and recommend courses of action.

Industry Context

This filing indicates continued interest from an investment group in a publicly traded health company, which is a common occurrence in the market where active investors seek to influence or benefit from corporate performance.

Stakeholder Impact

• Shareholders: Potential for increased shareholder advocacy and efforts to maximize shareholder value. Could also introduce uncertainty if the Reporting Persons pursue significant changes or dispose of shares.
• Management/Board: May face increased scrutiny or proposals from the Reporting Persons regarding strategic direction or governance.

Next Steps

• Reporting Persons may continue to engage with SANUWAVE Health's management, Board of Directors, and other shareholders.
• Reporting Persons may dispose of or enter into other transactions in the shares they beneficially own.
• Reporting Persons may act in concert with other shareholders for a common purpose.
• Reporting Persons may recommend courses of action to management and shareholders.

Key Dates

Recommendation

The increased stake by an investment group, coupled with their stated intent to engage with management to maximize shareholder value, could be seen as a positive catalyst. However, the filing is an amendment to an existing Schedule 13D, and the 'reserve the right' clauses indicate potential for future actions that could be either beneficial or disruptive. Without further details on the specific plans or the company's current performance, a 'hold' recommendation is prudent, advising investors to monitor the situation for concrete developments from either the company or the activist group.

Keywords

SANUWAVE Health, SWAV, Schedule 13D, Beneficial Ownership, Shareholder Activism, Investment Management, Common Stock, Equity Stake, Manchester Management